Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Airway basal cells are epithelial progenitor/stem cells located at the base of the airway epithelium, attached to the basal lamina. They maintain epithelial integrity by self-renewal and by differentiating into most other major airway epithelial cell types, especially after injury. Basal cells are defined by expression of marker proteins such as TP63, KRT5, KRT14, and sometimes YAP. They play critical roles not just in facilitating epithelial repair but also in mounting innate immune responses and communicating with other cell types via cytokine and growth factor release. Basal cell dysfunction, abnormal differentiation, or expansion are features of a number of airway diseases, including COPD, asthma, and various lung cancers. Therefore, although basal cells are not drug targets themselves, understanding their biology may inform future regenerative therapies, disease models, or cancer treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Airway basal cell.